Long and short term effects of growth hormone secretagogues on body composition

Long and short term effects of growth hormone secretagogues on body composition

Bibliographic Details
Main Author:	Lall, Sabrina
Published:	University of Cambridge 2001
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.621283

Similar Items

Hypothalamic actions of growth hormone secretagogues
by: Kumarnsit, Ekkasit
Published: (2003)

Transgenic studies of growth hormone secretagogues physiology
by: Balthasar, Nina
Published: (2001)

Neuroprotective actions of ghrelin and growth hormone secretagogues
by: Laura M. Frago, et al.
Published: (2011-09-01)

Growth Hormone Secretagogues and the Regulation of Calcium Signaling in Muscle
by: Elena Bresciani, et al.
Published: (2019-09-01)

The synthesis of a small library of prospective growth hormone secretagogues
by: Pejović Vojislav, et al.
Published: (1999-01-01)

Growth hormone secretagogues: history, mechanism of action, and clinical development
by: Junichi Ishida, et al.
Published: (2020-01-01)

The Growth Hormone Secretagogue Receptor: Its Intracellular Signaling and Regulation
by: Yue Yin, et al.
Published: (2014-03-01)

The synthesis of a small library of prospective growth hormone secretagogues
by: JELENA JOKSIMOVIC, et al.
Published: (1999-10-01)

Molecular characterization of growth hormone secretagogue receptor in black seabream, acanthopagrus schlegeli.
Published: (2003)

Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?
by: Elizabeth C Hersch, et al.
Published: (2008-03-01)

LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
by: Kripa Shankar, et al.
Published: (2021-11-01)

The Ghrelin/Growth Hormone Secretagogue Receptor System Is Involved in the Rapid and Sustained Antidepressant-Like Effect of Paeoniflorin
by: Yuan Zhang, et al.
Published: (2021-02-01)

Regional Differences in the Ghrelin-Growth Hormone Secretagogue Receptor Signalling System in Human Heart Disease
by: Rebecca Sullivan, BSc, et al.
Published: (2021-02-01)

Biological activity of a new Growth hormone secretagogue: study in fish and murine cell line
by: Rebeca Martínez
Published: (2016-09-01)

Development and Characterization of an F-labeled Ghrelin Peptidomimetic for Imaging the Cardiac Growth Hormone Secretagogue Receptor
by: Ahmed Abbas MSc, et al.
Published: (2018-11-01)

Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels
by: John T. Sigalos, et al.
Published: (2017-11-01)

Ghrelin and the Growth Hormone Secretagogue Receptor Axis : A Genetic Analysis of Regulatory Function In Growth and Metabolism in the Human
by: Gueorguiev, Maria
Published: (2007)

Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.
by: Ambavane V, et al.
Published: (2002-07-01)

LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling
by: Emilio R. Mustafá, et al.
Published: (2021-08-01)

Ghrelin transport across the blood–brain barrier can occur independently of the growth hormone secretagogue receptor
by: Elizabeth M. Rhea, et al.
Published: (2018-12-01)

Editorial Foreword: Comments on "Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging" || FREE PAPER ||
by: Richard F Walker
Published: (2008-03-01)

Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency
by: Michael B. Ranke
Published: (2021-09-01)

Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium.
by: Yi Ma, et al.
Published: (2012-01-01)

Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor.
by: Hosoda, Hiroshi
Published: (2011)

Obese and hypertensive elderly patient, with incipient diabetic nephropathy and previous cardiovascular event, long-term treated with secretagogues
by: Andrea Da Porto
Published: (2018-07-01)

Integration of Cell-Free Expression and Solid-State NMR to Investigate the Dynamic Properties of Different Sites of the Growth Hormone Secretagogue Receptor
by: Emelyne M. Pacull, et al.
Published: (2020-10-01)

Contribution of growth hormone secretagogue receptor (GHSR) signaling in the ventral tegmental area (VTA) to the regulation of social motivation in male mice
by: Su-Bin Park, et al.
Published: (2021-04-01)

Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone Therapy
by: Jan M. Wit, et al.
Published: (2019-12-01)

Long-Term Effects of Placental Growth on Overweight and Body Composition
by: Johan G. Eriksson, et al.
Published: (2012-01-01)

In vivo investigations of the effect of short- and long-term recombinant growth hormone treatment on DNA-methylation in humans.
by: Julia Kolarova, et al.
Published: (2015-01-01)

Fasting induces remodeling of the orexigenic projections from the arcuate nucleus to the hypothalamic paraventricular nucleus, in a growth hormone secretagogue receptor–dependent manner
by: Agustina Cabral, et al.
Published: (2020-02-01)

Expression profiling of human basophils: modulation by cytokines and secretagogues.
by: Donald MacGlashan
Published: (2015-01-01)

Baseline Body Composition in Prepubertal Short Stature Children with Severe and Moderate Growth Hormone Deficiency
by: Pawel Matusik, et al.
Published: (2016-01-01)

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

The effect of short-term hypothyroidism on growth hormone secretory responses to growth hormone-releasing hormone (1-29) and insulin-induced hypoglycemia
by: Dimitris Mytilinaios, et al.
Published: (2017-01-01)

Growth Hormone Improves Short-Term Growth in Patients with Temple Syndrome
by: Brightman, Diana S.
Published: (2018)

Effect of long-term Tai Chi practice on anabolic hormone and body composition in 50-65 years males
by: Ting-Ju Lin, et al.
Published: (2008)

Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome
by: Insook Jeong, et al.
Published: (2016-03-01)

Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
by: Miao-Miao Zhao, et al.
Published: (2021-09-01)

Effect of body mass index on peak growth hormone level after growth hormone stimulation test in children with short stature
by: Na Yeong Lee, et al.
Published: (2021-09-01)